164 related articles for article (PubMed ID: 19494365)
1. Novel alpha-fetoprotein-V messenger RNA isoforms in humans.
Tagaya H; Fukasawa H; Shoda T; Hoshi K; Hirata S
Reprod Sci; 2009 Aug; 16(8):794-801. PubMed ID: 19494365
[TBL] [Abstract][Full Text] [Related]
2. Novel human alpha-fetoprotein mRNA isoform lacking exon 1 identified in ovarian yolk sac tumor.
Fukasawa H; Iwamoto H; Hirata S; Shoda T; Yokota S; Nishi S; Hoshi K
J Soc Gynecol Investig; 2005 Sep; 12(6):456-62. PubMed ID: 15914041
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
4. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.
Reinholz MM; Zschunke MA; Roche PC
Gynecol Oncol; 2000 Nov; 79(2):264-71. PubMed ID: 11063655
[TBL] [Abstract][Full Text] [Related]
5. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
6. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
7. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Wang YL; Li G; Wu D; Liu YW; Yao Z
Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
[TBL] [Abstract][Full Text] [Related]
8. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver.
Zogopoulos G; Albrecht S; Pietsch T; Alpert L; von Schweinitz D; Lefèbvre Y; Goodyer CG
Cancer Res; 1996 Jul; 56(13):2949-53. PubMed ID: 8674047
[TBL] [Abstract][Full Text] [Related]
9. APC gene messenger RNA: novel isoforms that lack exon 7.
Oshima M; Sugiyama H; Kitagawa K; Taketo M
Cancer Res; 1993 Dec; 53(23):5589-91. PubMed ID: 8242607
[TBL] [Abstract][Full Text] [Related]
10. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
11. Targeted retardation of hepatocarcinoma cells by specific replacement of alpha-fetoprotein RNA.
Won YS; Lee SW
J Biotechnol; 2007 May; 129(4):614-9. PubMed ID: 17360066
[TBL] [Abstract][Full Text] [Related]
12. Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells.
Supriatna Y; Kishimoto T; Furuya M; Tochigi N; Ishiguro H; Tosh D; Ishikura H
Exp Mol Pathol; 2007 Jun; 82(3):316-21. PubMed ID: 16904665
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
[TBL] [Abstract][Full Text] [Related]
14. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
[TBL] [Abstract][Full Text] [Related]
15. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Yang X; Zhang Y; Zhang L; Zhang L; Mao J
Cancer Lett; 2008 Nov; 271(2):281-93. PubMed ID: 18657899
[TBL] [Abstract][Full Text] [Related]
16. Aromatase in human common epithelial ovarian neoplasms.
Kaga K; Sasano H; Harada N; Ozaki M; Sato S; Yajima A
Am J Pathol; 1996 Jul; 149(1):45-51. PubMed ID: 8686761
[TBL] [Abstract][Full Text] [Related]
17. Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements.
Ermak G; Jennings T; Boguniewicz A; Figge J
Clin Cancer Res; 1996 Aug; 2(8):1251-4. PubMed ID: 9816294
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Debruyne EN; Delanghe JR
Clin Chim Acta; 2008 Sep; 395(1-2):19-26. PubMed ID: 18538135
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel mRNA isoforms for human DNA polymerase beta.
Chyan YJ; Strauss PR; Wood TG; Wilson SH
DNA Cell Biol; 1996 Aug; 15(8):653-9. PubMed ID: 8769567
[TBL] [Abstract][Full Text] [Related]
20. The alpha-fetoprotein promoter is the target of Afr1-mediated postnatal repression.
Peyton DK; Huang MC; Giglia MA; Hughes NK; Spear BT
Genomics; 2000 Jan; 63(2):173-80. PubMed ID: 10673330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]